Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Statistics in Medicine|May 15, 1995
Inferring systemic exposure from a pharmacokinetic screen: model-free and model-based approachesJ R Nedelman, A H Karara, C T Chang, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 1999
The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactionsV Fischer, L Johanson, F Heitz, et al.Journal of Natural Products|June 27, 1998
Theonellapeptolide IIIe, a new cyclic peptolide from the New Zealand deep water sponge, Lamellomorpha strongylataS Li, E J Dumdei, J W Blunt, et al.Clinical Pharmacology and Therapeutics|May 1, 1996
Pharmacokinetics of abecarnil in patients with renal insufficiencyA H Karara, R F Frye, P E Hayes, et al.Pharmaceutical Research|April 1, 1990
Single- vs multiple-dose pharmacokinetics of clozapine in psychiatric patientsM G Choc, F Hsuan, G Honigfeld, et al.Drug Metabolism and Drug Interactions|January 1, 1988
S-oxidation of thioridazine to psychoactive metabolites: an oral dose-proportionality study in healthy volunteersB S Chakraborty, E M Hawes, G McKay, et al.Journal of Pharmaceutical Sciences|October 1, 1989
Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality studyB S Chakraborty, K K Midha, G McKay, et al.Pageof 3